Clinical Trials Logo

Clinical Trial Summary

Whether it is for oncology or personal reasons, fertility preservation allows participants to preserve their oocytes (eggs) at their current age and condition for a better chance of having a baby in the future. In order to proceed with fertility preservation, participants will need to undergo in vitro fertilization (IVF), which is standard practice, and take stimulation medication to stimulate production of more follicles. The combination of both Rekovelle and Menopur for fertility preservation may increase ovarian response to stimulation and increase the number of oocytes retrieved to give better chances of embryos once the oocytes will be fertilized. The goal in this study is to understand the effect of oxydative stress on the quality of oocytes. For the purpose of the study and to evaluate this connection, serum levels of oxidative stress and cf-DNA in your blood will be measured. Oocyte quality will also be assessed with Magenta, a prediction tool utilizing artificial intelligence (AI). This method is non-invasive and has no risks on the oocytes.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05372549
Study type Interventional
Source Clinique Ovo
Contact Nelly Delouya, RN
Phone 514.798.2000
Email n.delouya@cliniqueovo.com
Status Recruiting
Phase N/A
Start date June 1, 2022
Completion date December 31, 2024

See also
  Status Clinical Trial Phase
Recruiting NCT03954197 - Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients N/A
Recruiting NCT06074796 - The Determinants of Fertility Preservation in TRANSgender Patients.
Completed NCT01448460 - Oocyte Vitrification for In Vitro Fertilization (IVF) Patients and Women With Fertility Threatening Conditions N/A
Recruiting NCT02400827 - Contamination of Ovarian Tissue by RT-PCR in Participants With Solid Tumors N/A
Recruiting NCT02400970 - Contamination of Testicle Tissue by RT-PCR in Participants With Solid Tumors N/A
Recruiting NCT02895165 - PREgnancy and FERtility Registry
Not yet recruiting NCT03725280 - Micro RNA Profile in the Ovarian Follicle Fluid of Transgender Men
Recruiting NCT04904263 - Advisory Board on Cancer, Infertility and Pregnancy
Not yet recruiting NCT06289751 - Neoadjuvant Chemoimmunotherapy and Extrafascial Hysterectomy for IB2 Cervical Cancer Phase 2
Not yet recruiting NCT06289062 - Neoadjuvant Chemotherapy Plus Camrelizumab for FIGO Stage IB1 Cervical Cancer Phase 2
Completed NCT01696786 - Oocyte Cryopreservation N/A
Not yet recruiting NCT06468215 - Fertility Sparing Therapy for Patients With Stage IA G2 Endometrial Cancer N/A
Completed NCT01645241 - Evolutive Potential of Embryos Obtained From Oocytes After Luteal Phase Ovarian Stimulation N/A
Completed NCT01160315 - Efficiency of Gonadotropin-releasing Hormone (GnRH) Agonist in Preventing Chemotherapy Induced Ovarian Failure Phase 2/Phase 3
Not yet recruiting NCT06175832 - PPOS (Progestin Primed Ovarian Stimulation) and Corifollitropin Alfa (CFA) Cross-over Study Phase 4
Active, not recruiting NCT00827476 - Improving Human Ovarian Transplantation Phase 0
Completed NCT00380406 - PROtecting Ovaries and Fertility During Chemotherapy - The PROOF Trial Phase 3
Active, not recruiting NCT03817814 - Decisions of Young Women With Breast Cancer Regarding Fertility Preservation Before Cancer Treatment and Family Building After Treatment
Recruiting NCT05443737 - Evaluation of a Telehealth Oncofertility Care Intervention in Adolescent and Young Adult Cancer Patients Phase 3
Completed NCT05100498 - Web-based Oncofertility Support Tool for Reproductive-age Women With Breast Cancer N/A